Eledon Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q2 2024.
  • Eledon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$44.9M, a 31.7% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$109M, a 25.3% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117M, a 32.5% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$88M, a 155% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$34.5M, a 51.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$109M -$44.9M +$20.9M +31.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$129M -$23.6M -$12.9M -119% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q4 2023 -$117M -$30.1M +$28.3M +48.4% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-08-19
Q3 2023 -$145M -$9.91M +$565K +5.4% Jul 1, 2023 Sep 30, 2023 10-K/A 2024-08-19
Q2 2023 -$145M -$65.8M -$56.5M -611% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$88.9M -$10.8M -$908K -9.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q4 2022 -$88M -$58.4M -$49.6M -563% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-08-19
Q3 2022 -$38.4M -$10.5M -$654K -6.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$37.7M -$9.25M -$1.86M -25.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$35.9M -$9.86M -$1.37M -16.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$34.5M -$8.81M -$2.9M -49.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$31.6M -$9.82M -$3.67M -59.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$27.9M -$7.38M -$4.8M -186% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$23.1M -$8.5M -$322K -3.94% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$22.8M -$5.9M -$1.76M -42.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$21.1M -$6.14M -$3.25M -112% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$17.8M -$2.59M +$1.51M +36.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$19.3M -$8.18M -$3.3M -67.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$16M -$4.14M +$430K +9.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.4M -$2.89M +$603K +17.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$17M -$4.09M -$904K -28.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$16.1M -$4.88M -$2.08M -73.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$14.1M -$4.57M -$2.46M -117% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 -$11.6M -$3.5M -$526K -17.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$11.1M -$3.19M +$3.47M +52.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$14.5M -$2.81M -$1.43M -104% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$13.1M -$2.11M +$1.63M +43.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$14.7M -$2.97M -$935K -45.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$13.8M -$6.66M -$5.66M -565% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$8.15M -$1.37M +$10.1M +88% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$18.2M -$3.74M +$7.28M +66.1% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-03
Q3 2016 -$25.5M -$2.04M +$9.82M +82.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$35.3M -$1M +$7.96M +88.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$43.3M -$11.4M +$1.83M +13.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$45.1M -$11M -$4.81M -77.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$40.3M -$11.9M -$5.46M -85.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$34.8M -$8.96M -$3.11M -53.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$31.7M -$13.3M -$8.41M -174% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$23.3M -$6.21M -$683K -12.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$22.6M -$6.39M -$3.03M -89.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$19.6M -$5.85M -$1.41M -31.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$18.2M -$4.85M -$2.46M -103% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$15.7M -$5.53M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$3.37M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 -$4.45M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 -$2.39M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.